ArticleBMC public health2026
A decade of change: trends in drug and alcohol use in Iran (2010-2019).
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundDrug and alcohol use poses critical public health challenges. This study estimated the prevalence of drug and alcohol use in Iran for 2019 and assessed its trends over the last decade, comparing 2019 data with our previous estimates in 2013 and 2016.
methodIn 2019, 16,733 individuals from 31 provinces were recruited. Network scale-up methodology was applied to estimate the annual prevalence of drug and alcohol use. Results were adjusted for popularity, visibility, and recognition biases. Data from three successive national surveys conducted in 2013, 2016, and 2019 were used to analyze the trend of drug and alcohol use.
resultsAlcohol was the most commonly used substance, with an annual prevalence of 4,470 (4,370-4,570) per 100,000 population, and 41.7% of users reported frequent use. Among opioids, codeine (4,840 per 100,000), opium (2,220 per 100,000), and tramadol (1,830 per 100,000) were the most prevalent, with frequent use reported in 38.5% of codeine and 58.0% of tramadol use. Nearly 75.0% of individuals using opium, heroin, or methamphetamine engaged in frequent use. Methamphetamine (450 per 100,000) and Ritalin (390 per 100,000) were the most commonly used stimulants. Between 2013 and 2016, alcohol use increased by 6.6%, with another 16.9% rise from 2016 to 2019. Nonprescribed methadone use increased by 4.2% annually between 2016 and 2019. Opium use declined by 4.3%, while heroin and drug injection showed an increasing trend from 2013 to 2016, followed by a decline from 2016 to 2019.
conclusionThe increasing prevalence of drugs and alcohol is alarming. Understanding these trends is essential for shaping public health policies and interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.